IBA, a world leader in particle accelerator technology, today confirms that it has signed a contract with the Spanish Ministry of Health to install ten proton therapy systems across Spain as part of a significant public tender.

January 2, 2023 — IBA, a world leader in particle accelerator technology, today confirms that it has signed a contract with the Spanish Ministry of Health to install ten proton therapy systems across Spain as part of a significant public tender. This follows the announcement in August that IBA had qualified as the only supplier of the tender.

The total value of the contract to IBA is currently EUR 217 million, all taxes excluded, for the ten systems to be installed at nine different sites in Spain. The contract does not include the typical multi-year maintenance component which will be negotiated at a later stage. Revenue recognition will start in 2022.

The project is being funded by the Amancio Ortega Foundation, which signed an agreement with the Spanish Ministry of Health in 2021 under which the Foundation agreed to donate funds for the purchase of 10 proton therapy systems to be installed across Spain.

Olivier Legrain, Chief Executive Officer of IBA commented: "This significant contract win for IBA is testament to the world-class quality of our offering and validates our established status as the proton therapy market leader with the unique ability to respond to a contract of such scale. We look forward to working closely with the nine centers across Spain to deliver this life-saving treatment to their patients."

Luk Herremans, Executive Vice President of IBA Proton Therapy added: "Securing such a major public tender underlines the growing importance of proton therapy in the treatment of cancer, in a market that continues to see strong momentum globally with more clinical evidence being generated on the treatment modality than ever before. We welcome these new Spanish centers to our IBA Campus community, which is the largest in the world and where they will be able to both learn from and share with other members in order to provide cutting-edge cancer care to their patients.

For more information: www.iba-worldwide.com

Related Radioisotope Content:   

NorthStar Medical Radioisotopes Announces Supply Agreement with Aktis Oncology, Inc. for Alpha-Emitting Therapeutic Radioisotope Actinium-225 (Ac-225) 

NorthStar Medical Radioisotopes and Convergent Therapeutics Announce Supply Agreement for Therapeutic Radioisotope Actinium-225 (Ac-225)   

Update on HFR Reactor Outage – Medical Isotope Supply Returning to Normal   

Update on Unplanned Outage of the HFR Reactor   

SNMMI Issues Alert That HFR Outage Will Impact Isotope Supply   

NorthStar Medical Radioisotopes Advances Focus on Therapeutic and Specialized SPECT Radiopharmaceuticals   

How Nuclear Fusion is Revolutionizing Medical Isotope Production   

FDA Approves Additional Molybdenum-99 (Mo-99) Filling Lines at NorthStar Medical Radioisotopes   

Medical Isotope Industry Opposes Export of Highly Enriched Uranium for IRE   

IBA and NorthStar Medical Radioisotopes Expand Collaboration to Enable Global Availability of Tc-99m


Related Content

News | Radiology Business

May 20, 2024 — Associated Medical Professionals of NY (A.M.P.) announced that internationally recognized radiation ...

Time May 20, 2024
arrow
News | ASTRO

May 17, 2024 — Registration opens today for the American Society for Radiation Oncology's (ASTRO) 66th Annual Meeting ...

Time May 17, 2024
arrow
News | Radiation Therapy

May 16, 2024 — Today marks a significant milestone in cancer care with the introduction of bipartisan federal ...

Time May 16, 2024
arrow
News | FDA

May 14, 2024 — Indica Labs, the leading provider of digital pathology solutions, announced today that it received FDA ...

Time May 14, 2024
arrow
News | Radiology Business

May 14, 2024 — University Hospitals (UH) and Siemens Healthineers announce a 10-year strategic alliance that builds on ...

Time May 14, 2024
arrow
News | Artificial Intelligence

May 14, 2024 — Elekta announced the launch of its latest linear accelerator (linac), Evo*, a CT-Linac with new high ...

Time May 14, 2024
arrow
News | Radiopharmaceuticals and Tracers

May 8, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of ...

Time May 08, 2024
arrow
News | Treatment Planning

May 6, 2024 — Elekta announced the acquisition of Philips Healthcare’s Pinnacle Treatment Planning System (TPS) patent ...

Time May 06, 2024
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

One on One interviews with radiology trailblazers and historic FDA clearances made the top-read list for April. Take a ...

Time May 03, 2024
arrow
Feature | Radiation Dose Management | By Christine Book

Advances in the growing radiation dose management market are continually helping those who administer treatment to focus ...

Time May 03, 2024
arrow
Subscribe Now